Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race
Danish biotech group Zealand Pharma is developing an alternative obesity treatment to compete with big rivals
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Denmark Health | Eating Disorders & Weight Management | New Zealand Health | Obesity | Pharmaceuticals | Weight Loss